Liquid and Foam Sclerotherapy for Spider and Varicose Veins

Kathleen Gibson; Krissa Gunderson

doi:10.1016/j.suc.2017.11.010

Liquid and Foam Sclerotherapy for Spider and Varicose Veins

Surg Clin North Am. 2018 Apr;98(2):415-429. doi: 10.1016/j.suc.2017.11.010. Epub 2017 Dec 22.

Authors

Kathleen Gibson¹, Krissa Gunderson²

Affiliations

¹ Lake Washington Vascular Surgeons, 1135 116th Avenue Northeast, Suite 305, Bellevue, WA 98004, USA. Electronic address: drgibson@lkwv.com.
² Lake Washington Vascular Surgeons, 1135 116th Avenue Northeast, Suite 305, Bellevue, WA 98004, USA.

PMID: 29502781
DOI: 10.1016/j.suc.2017.11.010

Abstract

Sclerotherapy has wide applicability in treating venous disease at every stage of clinical disease. The various sclerosant drugs and formulations each have unique properties, utilities, and side effects. Treating physicians should be aware of the differences between agents, accounting for disease presentation, vein characteristics, and patient comorbidities when selecting the appropriate sclerosing agents. Successful outcomes rely on proper patient evaluation and assessment for contraindications to sclerotherapy. Thorough patient education regarding realistic expectations with sclerotherapy in terms of symptoms relief, recurrence, and improvement in appearance is of chief importance.

Keywords: Foam sclerotherapy; Sclerotherapy; Spider veins; Telangiectasia; Varicose veins.

Publication types

Review

MeSH terms

Dosage Forms
Humans
Sclerosing Solutions / therapeutic use*
Sclerotherapy / adverse effects
Sclerotherapy / methods*
Telangiectasis / therapy*
Treatment Outcome
Varicose Veins / diagnosis
Varicose Veins / therapy*

Substances

Dosage Forms
Sclerosing Solutions